Current evidence points towards rTMS’s efficacy in alleviating ET symptoms by increasing GABAergic tone (GABA-A and GABA-B receptors shown in top right) and modulating the oscillatory network (cerebello-thalamo-cortical circuit shown in bottom right) to reduce tremors in the upper limbs. The gene discussed is GABBR1; the disease is essential thrombocythemia.